Home › Forums › Oral & Maxillofacial surgery › Bis-Phosphonates & Osteo-Necrosis of the Jaw (‘Dead Jaw Syndrome’)
Welcome Dear Guest
To create a new topic please register on the forums. For help contact : discussdentistry@hotmail.com
- This topic has 3 replies, 2 voices, and was last updated 24/01/2012 at 5:21 pm by Drsumitra.
-
AuthorPosts
-
07/11/2011 at 5:06 pm #10101drsushantOfflineRegistered On: 14/05/2011Topics: 253Replies: 277Has thanked: 0 timesBeen thanked: 0 times
Bis-Phosphonate medications are widely used in the
treatment of bone diseases including osteoporosis and
Paget’s disease and in some cancers. They are used in
Bis-Phosphonate medications are widely used in the
treatment of bone diseases including osteoporosis and
Paget’s disease and in some cancers. They are used in
low oral doses to treat osteoporosis and to prevent
fractures.They are used in high IV (intravenous) doses in cancer to
prevent complications when it spreads to bone. They have
been used for over 10 years.Bis-Phosphonates reduce the risk of fractures (broken
bones) by about 50%. As up to 30% of patients can die in
the first 12 months after a hip fracture, bis-phosphonates
are likely to reduce the numbers of deaths associated with
this and other fractures due to osteoporosis.These benefits outweigh the risk of side effects of bis-
phosphonates, which are minimal. Osteo-Necrosis of the
jaw (ONJ) is a very rare side-effect of bis-phosphonates.However, you should be aware of this rare but potentially
serious association of bis-phosphonate treatment and take
appropriate measures to help prevent it.What is Osteo-Necrosis of the Jaw (‘Dead Jaw
Syndrome’)?Osteo-Necrosis means death of bone. Osteo-Necrosis of
the Jaw (ONJ) is defined as an area of exposed bone (not
covered by gum) in the jaw region that does not heal within
8 weeks of identification. The exact cause of BONJ is
currently unknown.What is the risk of developing this complication?
The risk of developing Bis-phosphonate-associated ONJ
ranges between 1/10,000 to 1/100,000 for patients taking
oral bis-phosphonate for treatment of osteoporosis or
Paget’s disease. The risk is much higher, ranging between
1% and 10%, for patients with cancers on high IV doses.What are the risk factors for Bis-phosphonate-associated
ONJ?Use of high-dose IV bis-phosphonate
Longer duration of treatment with bis-phosphonate
Steroid use (Prednisolone, Dexamethasone etc.)
Alcohol abuse and tobacco use
People suffering from cancer
Poor dental hygiene and those who undergo a dental
procedure such as dental extraction
Diabetes mellitusWhat are the symptoms of BONJ?
Severe jaw pain
Numbness of the jaw
Swelling and infection of the jaw region
Loosening of teeth and exposed boneThese symptoms may occur spontaneously or more often,
following tooth extraction.07/11/2011 at 5:09 pm #14801drsushantOfflineRegistered On: 14/05/2011Topics: 253Replies: 277Has thanked: 0 timesBeen thanked: 0 times07/11/2011 at 5:10 pm #14802drsushantOfflineRegistered On: 14/05/2011Topics: 253Replies: 277Has thanked: 0 timesBeen thanked: 0 timesWhat should I do to minimize the risk of BONJ?
Inform your dentist that you are taking bis-phosphonates
especially if you plan to have a dental procedure
Maintain good oral hygiene, attend regular dental visits and
report any oral problems to your dentist.
If you are planning to take bis-phosphonates for cancer, you
should have a dental evaluation prior to starting the medication
and then every 6 to 12 months or as directed by your dentist.
Discuss possible side-effects with your GPCan BONJ be treated?
There is no cure for BONJ to date.
Stopping bis-phosphonates may not alter the progression of the
disease. You should therefore discuss with your doctor whether or
not it is appropriate for you to cease bis-phosphonates.What are the common bis-phosphonates used in treatment of
osteoporosis & cancer?Alendronate (Fosamax, Fosamax plus, Alendro) and Risedronate
(Actonel, Actonel Combi) are most often used for osteoporosis
treatment in oral form. Pamidronate (Aredia, Pamisol) and
Zolendronic Acid (Zometa) are given by IV dose in cancer.Note: Intravenous or IV means that a medication is injected directly
into the veinImportant Points
The main risk group for BONJ are patients on IV doses who have
CANCER — NOT patients on oral doses for osteoporosis.The overall benefits of oral bis-phosphonates in preventing
complications (including death) from minimal trauma fractures due
to osteoporosis generally far outweigh the risk of developing BONJ.24/01/2012 at 5:21 pm #15087DrsumitraOfflineRegistered On: 06/10/2011Topics: 238Replies: 542Has thanked: 0 timesBeen thanked: 0 timesPeople in South Africa are more at risk for mouth or throat cancer than they were in recent years. The reason is simple: there’s a shortage of dentists in the country.
There are fewer than 3,500 dentists who practicing in the entire country, according to the South African Dental Association. With that low number of dentists, there’s no conceivable way for people to visit the dentist regularly.
Some studies show that there are 500,000 people for each dentist in South Africa. Comparatively speaking, there is a dentist for about every 1,700 people in the United States—or slightly more or less, depending on the specific geography region.
With fewer dentists and dental visits, there are fewer chances to diagnose some type of mouth cancer or oral cancer.
There are some people that are going years between visits to the dentist. That problem, combined with smoking cigarettes and marijuana, are causing many issues for the country’s citizens. These issues are only compounded by unprotected sex and oral sex, which makes a person more susceptible to oral cancer.
The South African Dental Association states that the possibility of dying from some type of oral cancer is high based on the lack of dental visits. The reason is the cancer is diagnosed at a stage in which it’s too late to treat the problem because it has likely spread.
-
AuthorPosts
- You must be logged in to reply to this topic.